Skip to content
10-Q

Quarterly Report

Ocera Therapeutics, Inc.

0001274644-17-000040

← back to feed
Filed
May 9, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 30, 2017 26.51M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$6.43M
Operating Cash Flow Q1 2017 · Mar 31, 2016 −$5.23M
Cash And Equivalents Q1 2017 · Mar 31, 2017 $25.18M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $24.61M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $32.43M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $35.92M
Stockholders Equity Q1 2017 · Mar 31, 2017 $13.52M
Stockholders Equity Q1 2017 · Dec 31, 2016 $15.74M
Current Liabilities Q1 2017 · Mar 31, 2017 $13.07M
Current Liabilities Q1 2017 · Dec 31, 2016 $13.76M
Total Liabilities Q1 2017 · Mar 31, 2017 $13.07M
Total Liabilities Q1 2017 · Dec 31, 2016 $13.9M
Current Assets Q1 2017 · Mar 31, 2017 $25.93M
Current Assets Q1 2017 · Dec 31, 2016 $28.94M
Total Assets Q1 2017 · Mar 31, 2017 $26.59M
Total Assets Q1 2017 · Dec 31, 2016 $29.64M
Sga Expense Q1 2017 · Mar 31, 2017 $2.52M
Sga Expense Q1 2017 · Mar 31, 2016 $2.55M
Rd Expense Q1 2017 · Mar 31, 2017 $3.9M
Rd Expense Q1 2017 · Mar 31, 2016 $4.75M
Net Income Q1 2017 · Mar 31, 2017 −$6.68M
Net Income Q1 2017 · Mar 31, 2016 −$7.51M